Bayer AG (BAYN) Given a €125.00 Price Target by J P Morgan Chase & Co Analysts

J P Morgan Chase & Co set a €125.00 ($147.06) price objective on Bayer AG (FRA:BAYN) in a research report released on Wednesday. The firm currently has a buy rating on the healthcare company’s stock.

Several other analysts also recently issued reports on BAYN. UBS AG set a €125.00 ($147.06) target price on Bayer AG and gave the company a buy rating in a research note on Monday. Deutsche Bank AG set a €124.00 ($145.88) target price on Bayer AG and gave the company a buy rating in a research note on Friday, October 27th. Goldman Sachs Group, Inc. (The) set a €125.00 ($147.06) target price on Bayer AG and gave the company a buy rating in a research note on Friday, October 27th. S&P Global set a €126.00 ($148.24) target price on Bayer AG and gave the company a buy rating in a research note on Thursday, October 26th. Finally, Nord/LB set a €102.00 ($120.00) target price on Bayer AG and gave the company a neutral rating in a research note on Thursday, October 26th. Eight analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company. Bayer AG currently has an average rating of Buy and a consensus target price of €122.24 ($143.81).

TRADEMARK VIOLATION WARNING: “Bayer AG (BAYN) Given a €125.00 Price Target by J P Morgan Chase & Co Analysts” was first reported by Community Financial News and is the sole property of of Community Financial News. If you are viewing this piece on another domain, it was copied illegally and reposted in violation of international copyright & trademark laws. The legal version of this piece can be accessed at https://www.com-unik.info/2017/11/02/bayer-ag-bayn-given-a-125-00-price-target-by-j-p-morgan-chase-co-analysts.html.

Bayer AG Company Profile

.

Analyst Recommendations for Bayer AG (FRA:BAYN)

What are top analysts saying about Bayer AG? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Bayer AG and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit